|
|
TTD Drug ID:
DNC009250
Drug
Information |
Name | 2,7-Bis[2-(piperidino)acetamido]anthraquinone | Indication | Not Available | Experimental | Structure |
Click to save drug structure in 3D MOL format
Click to save drug structure in 2D MOL format
| InChI | 1S/C28H32N4O4/c33-25(17-31-11-3-1-4-12-31)29-19-7-9-21-23(15-19)2 8(36)24-16-20(8-10-22(24)27(21)35)30-26(34)18-32-13-5-2-6-14-32/h 7-10,15-16H,1-6,11-14,17-18H2,(H,29,33)(H,30,34) | InChIKey | IOHQNFPYEZQWLH-UHFFFAOYSA-N | Canonical SMILES | C1CCN(CC1)CC(=O)NC2=CC3=C(C=C2)C(=O)C4=C(C3=O)C=C(C=C4)NC(=O)CN5CCCCC5 | Target | Telomerase reverse transcriptase |  | Inhibitor | [1] | Ref 1 | Bioorg Med Chem. 2008 Jul 15;16(14):6976-86. Epub 2008 Jun 2.Synthesis, human telomerase inhibition and anti-proliferative studies of a series of 2,7-bis-substituted amido-anthraquinone derivatives. To Reference |
Welcome
to sign our Guestbook.
If you
find any error in data or bug in web service, please kindly report it
to Dr.
Zhu.
Dr.
Chen Yuzong
Deputy Director of Center
for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|